Innovation centre opens
PerkinElmer, Inc., (Waltham, Massachusetts, USA) has built a personalized health innovation centre of excellence.
PerkinElmer, Inc., (Waltham, Massachusetts, USA) has built a personalized health innovation centre of excellence. The centre will focus on accelerating scientific innovation to help researchers who are working to eradicate disease and extend the quality and longevity of life.
The centre will bring together leaders from PerkinElmer’s chemistry, biochemistry, cell biology, molecular biology and reagent development R&D teams. They will focus on the development of applications solutions in genomics, imaging, biomarkers, biotherapeutics, targeted small molecule development and cell‑based assay solutions. The centre will also showcase a complete solutions-based demonstration laboratory for customers and collaborators.
The centre will be located at the company’s facility in Hopkinton, Massachusetts, USA, and is hoped to be fully operational by late 2012.Kevin Hrusovsky, President, Life Sciences & Technology, PerkinElmer, said, “We are delighted to establish our new centre of excellence, which will serve as an exciting example of PerkinElmer’s commitment to, and culture of, innovation. The expertise promoted by the centre will help bring novel and disruptive solutions to our customers, aiding their research in next generation treatments, early detection and disease prevention.”
For more information please visit www.perkinelmer.comThis story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
